Tech Company Financing Transactions
Qkine Funding Round
On 12/15/2022, Qkine raised $4.9 million in investment from Downing Ventures and ParkWalk Advisors.
Transaction Overview
Company Name
Announced On
12/15/2022
Transaction Type
Venture Equity
Amount
$4,880,000
Round
Undisclosed
Investors
Downing Ventures (Lead Investor)
ParkWalk Advisors (Lead Investor)
Proceeds Purpose
The company intends to use the funds to enable substantial scaling of manufacturing, R&D and commercial functions and to expand into additional global markets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
152 Cambridge Science Park
Cambridge, CB4 0GN
UK
Cambridge, CB4 0GN
UK
Phone
Website
Email Address
Overview
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cellular agriculture sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF-ß1 for chemically defined stem cell media, and animal-free HGF (NK1).
Management Team
Browse more venture capital transactions:
Prev: 12/15/2022: Sweep venture capital transaction
Next: 12/16/2022: Infinity AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs